EnPress Publisher requests all members involved in the journal publishing process to adhere to the Core Practices on publication ethics as stipulated by Committee on Publication Ethics (COPE) in compliance with the information and guidelines on handling publishing ethics allegations as described in the Publishing Ethics Resource Kit (PERK).
The journals strictly adhere to the guidelines and best practices, which include Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journals Editors (ICMJE) and the Principles of Transparency and Best Practice in Scholarly Publishing developed by Committee on Publication Ethics (COPE), Directory of Open Access Journals (DOAJ), Open Access Scholarly Publishers Association (OASPA) and World Association of Medical Editors (WAME).
The publisher journal editors take all possible misconducts seriously. The Editors, authors or readers can forward their concerns to the journal if they find out that the description in a submitted article may constitute an academic fraud, research misconduct or publication malpractice. The concerns or complaints on the possible allegations submitted to the journal will be dealt with promptly and appropriately according to the procedure set out in the COPE flowchart on complaints and in PERK. The complainant may direct all inquiries and correspondence to the publisher at firstname.lastname@example.org.
EnPress Publisher adopts a zero-tolerance policy concerning any academic misconducts and ethical violations in research and publication regardless of the severity of these issues. The violations include plagiarism, falsification of research, data fabrication, submitting manuscripts of others as one’s own, submission of same manuscript to different publication venues at the same time and breached intellectual property rights. In cases of suspected misconduct and ethical violation, a panel will be formed to investigate the allegation. If the allegation is supported by evidence, the submitted manuscript in question will be declined for consideration in the journal and all authors will be informed in this regard. A retraction initiated by authors or by the journal is required to take place if the paper has already been published, and the retraction will be made public. Authors of the work in question will receive the panel’s Decision via email and all appeals regarding the decision will have to be made to the publisher at email@example.com within 30 days of the decision date.